DOI:
10.1055/s-00000021
Gesundheitsökonomie & Qualitätsmanagement
LinksClose Window
References
Ruof J, Scherer J, Schulenburg JM.
Appropriate comparative treatments for early benefit assessment (EBA) in Germany. Comparing the suggestions of the Joint Federal Committee (GBA) and the pharmaceutical companies. Abstract PRM 162; ISPOR 15th Annual European Congress, 3–7 November 2012, Berlin, Germany.
Value Health 2012;
15 (07) A 490
We do not assume any responsibility for the contents of the web pages of other providers.